Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer.
Bennett
Charles L
CL
Angelotta
Cara
C
Yarnold
Paul R
PR
Evens
Andrew M
AM
Zonder
Jeffrey A
JA
Raisch
Dennis W
DW
Richardson
Paul
P
D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology
D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide